SIM
KYTX icon

Spark Investment Management’s Kyverna Therapeutics KYTX Stock Holding History

Spark Investment Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+25,100
New +$223K 0.44% 38

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Spark Investment Management's KYTX Position: Q2 2026 in Review

Spark Investment Management opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 25,100 shares worth $224K. The stake represents 0.44% of the portfolio and ranks #38 among its holdings.

121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Spark Investment Management held 25,100 shares of Kyverna Therapeutics worth $224K as of Q2 2026.
  • Kyverna Therapeutics was a new Spark Investment Management position in Q2 2026.
  • Kyverna Therapeutics made up 0.44% of Spark Investment Management's portfolio in Q2 2026, its #38 holding.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.